Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Verapamil Dosing for Migraine Prevention

Efficacy Evidence

  • A full therapeutic trial of verapamil for migraine prevention requires at least 2-3 months as clinical benefits may take time to develop 1
  • Verapamil has shown significant efficacy for migraine prevention in placebo-controlled trials, with two out of three trials demonstrating significant differences favoring verapamil over placebo 1

Comparative Efficacy

  • The American Academy of Family Physicians suggests that verapamil appears to have similar efficacy to propranolol in reducing headache frequency 1
  • Beta-blockers have stronger overall evidence for migraine prevention, with propranolol 80-240 mg/day and timolol 20-30 mg/day being effective options 2
  • Amitriptyline, at a dose of 25-150 mg daily, is the only antidepressant with consistent evidence for migraine prevention, according to the American Family Physician 1

Important Considerations

  • High dropout rates in some verapamil studies raise concerns about long-term tolerability, as reported by the American Family Physician 1
  • Verapamil is generally considered after first-line options like propranolol, timolol, or amitriptyline, as stated in Praxis Medical Insights 2

Pitfalls to Avoid

  • Verapamil is indicated when patients have ≥2 attacks per month with significant disability or use acute medications more than twice weekly, according to Praxis Medical Insights 3

REFERENCES

2

Propranolol Dosing for Migraine Prevention [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Migraine Prevention with Beta-Blockers [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025